durvalumab
astrazeneca
['topaz-1', 'durvalumab']
well, this publication is extremely timely results from topaz-1, presented initially at #gi22, now in for #asco22 day 1. durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer | nejm evidence 
Physician-Scientist/Clinical Cancer Biologist. Clinical focus: GI Oncology/Neuro-Oncology. In lab: #TunnelingNanotubes #Exosomes and drivers of Chemoresistance